Kumiko Kaifu

496 total citations
15 papers, 426 citations indexed

About

Kumiko Kaifu is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kumiko Kaifu has authored 15 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Nephrology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kumiko Kaifu's work include Renin-Angiotensin System Studies (4 papers), Advanced Glycation End Products research (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Kumiko Kaifu is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Advanced Glycation End Products research (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Kumiko Kaifu collaborates with scholars based in Japan, United States and Antigua and Barbuda. Kumiko Kaifu's co-authors include Masakazu Kohno, Akira Nishiyama, Taiga Hara, Hideyasu Kiyomoto, Hirofumi Hitomi, Kumiko Moriwaki, Yoshiko Fujita, Seiya Okuda, Seiji Ueda and Sho‐ichi Yamagishi and has published in prestigious journals such as Kidney International, Hypertension and Nephrology Dialysis Transplantation.

In The Last Decade

Kumiko Kaifu

14 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumiko Kaifu Japan 12 194 118 88 86 81 15 426
Mikihiro Nakayama Japan 10 169 0.9× 112 0.9× 113 1.3× 44 0.5× 56 0.7× 16 418
Dalia El-Lebedy Egypt 12 95 0.5× 60 0.5× 98 1.1× 71 0.8× 56 0.7× 29 453
Yuichiro Makita Japan 13 109 0.6× 114 1.0× 128 1.5× 73 0.8× 166 2.0× 22 505
Chikage Sato Japan 8 290 1.5× 50 0.4× 169 1.9× 146 1.7× 114 1.4× 9 551
Toshihide Shike Japan 10 90 0.5× 78 0.7× 117 1.3× 56 0.7× 159 2.0× 15 443
Nobuo Kajitani Japan 9 340 1.8× 68 0.6× 168 1.9× 161 1.9× 127 1.6× 10 640
Sheryl K. Cooney United States 10 85 0.4× 64 0.5× 82 0.9× 54 0.6× 151 1.9× 10 325
Daisho Hirota Japan 6 327 1.7× 44 0.4× 130 1.5× 162 1.9× 103 1.3× 6 519
Kamie Snow United States 5 76 0.4× 60 0.5× 120 1.4× 94 1.1× 120 1.5× 6 361
Ryo Kodera Japan 10 372 1.9× 65 0.6× 170 1.9× 188 2.2× 138 1.7× 16 648

Countries citing papers authored by Kumiko Kaifu

Since Specialization
Citations

This map shows the geographic impact of Kumiko Kaifu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumiko Kaifu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumiko Kaifu more than expected).

Fields of papers citing papers by Kumiko Kaifu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumiko Kaifu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumiko Kaifu. The network helps show where Kumiko Kaifu may publish in the future.

Co-authorship network of co-authors of Kumiko Kaifu

This figure shows the co-authorship network connecting the top 25 collaborators of Kumiko Kaifu. A scholar is included among the top collaborators of Kumiko Kaifu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumiko Kaifu. Kumiko Kaifu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kaifu, Kumiko, Seiji Ueda, Nobutaka Nakamura, et al.. (2018). Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4. Microvascular Research. 120. 90–93. 23 indexed citations
2.
Kobori, Hiroyuki, et al.. (2014). Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease. Journal of the Renin-Angiotensin-Aldosterone System. 15(4). 505–508. 17 indexed citations
3.
Fukami, Kei, Sho‐ichi Yamagishi, Kumiko Kaifu, et al.. (2013). Telmisartan inhibits AGE-induced podocyte damage and detachment. Microvascular Research. 88. 79–83. 26 indexed citations
4.
Nakayama, Yosuke, Seiji Ueda, Sho‐ichi Yamagishi, et al.. (2013). Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury. Kidney International. 85(3). 570–578. 43 indexed citations
5.
Ando, Ryotaro, Seiji Ueda, Sho‐ichi Yamagishi, et al.. (2013). Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction. Diabetes and Vascular Disease Research. 10(5). 436–441. 55 indexed citations
6.
Kaifu, Kumiko, et al.. (2012). Abstract 399: The Circadian Rhythm of Plasma Angiotensinogen in Healthy Volunteers. Hypertension. 60(suppl_1). 1 indexed citations
7.
Sofue, Tadashi, Hideyasu Kiyomoto, Hiroyuki Kobori, et al.. (2012). Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic Rats. American Journal of Hypertension. 25(5). 604–611. 30 indexed citations
8.
Kobori, Hiroyuki, Tadashi Sofue, Kumiko Kaifu, et al.. (2012). Important Aspects of Urine Sampling for Angiotensinogen Measurement: Time and Preservation Conditions in Healthy Individuals. The Tohoku Journal of Experimental Medicine. 228(4). 333–339. 5 indexed citations
9.
Tahara, Nobuhiro, Sho‐ichi Yamagishi, Masayoshi Takeuchi, et al.. (2012). Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans. Clinical Biochemistry. 46(4-5). 300–303. 34 indexed citations
10.
Hitomi, Hirofumi, Kumiko Kaifu, Yoshiko Fujita, et al.. (2011). Angiotensin II Shifts Insulin Signaling Into Vascular Remodeling From Glucose Metabolism in Vascular Smooth Muscle Cells. American Journal of Hypertension. 24(10). 1149–1155. 15 indexed citations
11.
Hara, Taiga, Hideyasu Kiyomoto, Hirofumi Hitomi, et al.. (2009). Low-density lipoprotein apheresis for haemodialysis patients with peripheral arterial disease reduces reactive oxygen species production via suppression of NADPH oxidase gene expression in leucocytes. Nephrology Dialysis Transplantation. 24(12). 3818–3825. 21 indexed citations
12.
Kaifu, Kumiko, Hideyasu Kiyomoto, Keisuke Matsubara, et al.. (2008). Insulin attenuates apoptosis induced by high glucose via the PI3-kinase/Akt pathway in rat peritoneal mesothelial cells. Nephrology Dialysis Transplantation. 24(3). 809–815. 18 indexed citations
13.
Hara, Taiga, Hideyasu Kiyomoto, Tadashi Sofue, et al.. (2007). Unsuccessful Management for Renal Failure Induced by Glycogen Storage Disease Type-I (Von Gierke Disease) in Peritoneal Dialysis. Nihon Naika Gakkai Zasshi. 96(4). 775–777.
14.
Hitomi, Hirofumi, Hideyasu Kiyomoto, Akira Nishiyama, et al.. (2007). Aldosterone Suppresses Insulin Signaling Via the Downregulation of Insulin Receptor Substrate-1 in Vascular Smooth Muscle Cells. Hypertension. 50(4). 750–755. 116 indexed citations
15.
Moriwaki, Kumiko, Hideyasu Kiyomoto, Hirofumi Hitomi, et al.. (2006). Interferon-γ enhances superoxide production in human mesangial cells via the JAK–STAT pathway. Kidney International. 70(4). 788–793. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026